Insider · CIK 0001834440
Jeffrey Richard Fieler
Files at PCT (PureCycle Technologies, Inc.). First filing -, latest -.
In brief
Jeffrey Richard Fieler files SEC Form 4 as director at PCT (PureCycle Technologies, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jeffrey Richard Fieler has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 30, 2025 | PCT PureCycle Technologies, Inc. | DDisposition to issuer Common Stock | -9,675 | $0.00 | $0 | 1,973,428 | Nov 4, 2025 |
| Oct 30, 2025 | PCT PureCycle Technologies, Inc. | FTax withholding Common Stock | -2,902 | $11.34 | $33k | 1,970,526 | Nov 4, 2025 |
| May 8, 2025 | PCT PureCycle Technologies, Inc. | AGrant or award Common Stock | +19,349 | $0.00 | $0 | 1,983,103 | May 9, 2025 |
Questions about Jeffrey Richard Fieler
Answered from the filings on this page, as of the latest one.
Is Jeffrey Richard Fieler buying or selling?
Jeffrey Richard Fieler has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jeffrey Richard Fieler's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jeffrey Richard Fieler has 0.
Where does Jeffrey Richard Fieler file Form 4?
Jeffrey Richard Fieler has filed Form 4 at PCT (PureCycle Technologies, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.